series-a
Stage
1
Investors
About
Avammune Therapeutics is an R&D-driven drug discovery company developing novel small molecule therapeutics for hard-to-treat solid tumors, focusing on immuno-oncology and targeted cancer therapies.
Explore Avammune Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.